Implant Poised to Transform Macular Degeneration Treatment Implant Poised to Transform Macular Degeneration Treatment

A system that delivers ranibizumab without injections could be a turning point for patients with neovascular age-related macular degeneration, results from the highly anticipated LADDER trial show.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Related Links:

Br J Ophthalmol. 2021 Sep 13:bjophthalmol-2021-319383. doi: 10.1136/bjophthalmol-2021-319383. Online ahead of print.ABSTRACTOBJECTIVE: Predicting the impact of neovascular age-related macular degeneration (nAMD) service disruption on visual outcomes following national lockdown in the UK to contain SARS-CoV-2.METHODS AND ANALYSIS: This retrospective cohort study includes deidentified data from 2229 UK patients from the INSIGHT Health Data Research digital hub. We forecasted the number of treatment-naïve nAMD patients requiring anti-vascular endothelial growth factor (anti-VEGF) initiation during UK lockdown (16 March 2...
Source: The British Journal of Ophthalmology - Category: Opthalmology Authors: Source Type: research
CONCLUSIONS: AMD, cataract and DRED but not glaucoma are associated with an increased risk of dementia. Individuals with both ophthalmic and systemic conditions are at higher risk of dementia compared with those with an ophthalmic or systemic condition only.PMID:34518160 | DOI:10.1136/bjophthalmol-2021-319508
Source: The British Journal of Ophthalmology - Category: Opthalmology Authors: Source Type: research
Br J Ophthalmol. 2021 Sep 13:bjophthalmol-2021-319383. doi: 10.1136/bjophthalmol-2021-319383. Online ahead of print.ABSTRACTOBJECTIVE: Predicting the impact of neovascular age-related macular degeneration (nAMD) service disruption on visual outcomes following national lockdown in the UK to contain SARS-CoV-2.METHODS AND ANALYSIS: This retrospective cohort study includes deidentified data from 2229 UK patients from the INSIGHT Health Data Research digital hub. We forecasted the number of treatment-naïve nAMD patients requiring anti-vascular endothelial growth factor (anti-VEGF) initiation during UK lockdown (16 March 2...
Source: The British Journal of Ophthalmology - Category: Opthalmology Authors: Source Type: research
CONCLUSIONS: AMD, cataract and DRED but not glaucoma are associated with an increased risk of dementia. Individuals with both ophthalmic and systemic conditions are at higher risk of dementia compared with those with an ophthalmic or systemic condition only.PMID:34518160 | DOI:10.1136/bjophthalmol-2021-319508
Source: The British Journal of Ophthalmology - Category: Opthalmology Authors: Source Type: research
Br J Ophthalmol. 2021 Sep 13:bjophthalmol-2021-319383. doi: 10.1136/bjophthalmol-2021-319383. Online ahead of print.ABSTRACTOBJECTIVE: Predicting the impact of neovascular age-related macular degeneration (nAMD) service disruption on visual outcomes following national lockdown in the UK to contain SARS-CoV-2.METHODS AND ANALYSIS: This retrospective cohort study includes deidentified data from 2229 UK patients from the INSIGHT Health Data Research digital hub. We forecasted the number of treatment-naïve nAMD patients requiring anti-vascular endothelial growth factor (anti-VEGF) initiation during UK lockdown (16 March 2...
Source: The British Journal of Ophthalmology - Category: Opthalmology Authors: Source Type: research
CONCLUSIONS: AMD, cataract and DRED but not glaucoma are associated with an increased risk of dementia. Individuals with both ophthalmic and systemic conditions are at higher risk of dementia compared with those with an ophthalmic or systemic condition only.PMID:34518160 | DOI:10.1136/bjophthalmol-2021-319508
Source: The British Journal of Ophthalmology - Category: Opthalmology Authors: Source Type: research
Br J Ophthalmol. 2021 Sep 13:bjophthalmol-2021-319383. doi: 10.1136/bjophthalmol-2021-319383. Online ahead of print.ABSTRACTOBJECTIVE: Predicting the impact of neovascular age-related macular degeneration (nAMD) service disruption on visual outcomes following national lockdown in the UK to contain SARS-CoV-2.METHODS AND ANALYSIS: This retrospective cohort study includes deidentified data from 2229 UK patients from the INSIGHT Health Data Research digital hub. We forecasted the number of treatment-naïve nAMD patients requiring anti-vascular endothelial growth factor (anti-VEGF) initiation during UK lockdown (16 March 2...
Source: The British Journal of Ophthalmology - Category: Opthalmology Authors: Source Type: research
CONCLUSIONS: AMD, cataract and DRED but not glaucoma are associated with an increased risk of dementia. Individuals with both ophthalmic and systemic conditions are at higher risk of dementia compared with those with an ophthalmic or systemic condition only.PMID:34518160 | DOI:10.1136/bjophthalmol-2021-319508
Source: The British Journal of Ophthalmology - Category: Opthalmology Authors: Source Type: research
Br J Ophthalmol. 2021 Sep 13:bjophthalmol-2021-319383. doi: 10.1136/bjophthalmol-2021-319383. Online ahead of print.ABSTRACTOBJECTIVE: Predicting the impact of neovascular age-related macular degeneration (nAMD) service disruption on visual outcomes following national lockdown in the UK to contain SARS-CoV-2.METHODS AND ANALYSIS: This retrospective cohort study includes deidentified data from 2229 UK patients from the INSIGHT Health Data Research digital hub. We forecasted the number of treatment-naïve nAMD patients requiring anti-vascular endothelial growth factor (anti-VEGF) initiation during UK lockdown (16 March 2...
Source: The British Journal of Ophthalmology - Category: Opthalmology Authors: Source Type: research
CONCLUSIONS: AMD, cataract and DRED but not glaucoma are associated with an increased risk of dementia. Individuals with both ophthalmic and systemic conditions are at higher risk of dementia compared with those with an ophthalmic or systemic condition only.PMID:34518160 | DOI:10.1136/bjophthalmol-2021-319508
Source: The British Journal of Ophthalmology - Category: Opthalmology Authors: Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Health | Lucentis | Opthalmology | Ranibizumab Injection